Predictive Oncology, Inc.
(NASDAQ : POAI)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABTAbbott Laboratories 2.49%103.430.8%$756.63m
TMOThermo Fisher Scientific, Inc. 1.02%422.411.0%$622.86m
ISRGIntuitive Surgical, Inc. 2.46%673.732.4%$492.93m
MDTMedtronic Plc 1.90%103.190.6%$481.51m
DHRDanaher Corp. 1.81%207.180.7%$449.88m
BDXBecton, Dickinson & Co. 1.35%224.151.0%$422.13m
INOInovio Pharmaceuticals, Inc. 10.22%16.945.9%$416.15m
QDELQuidel Corp. 2.51%196.777.7%$403.46m
DXCMDexCom, Inc. 5.32%402.367.9%$319.09m
SYKStryker Corp. 2.90%204.731.3%$282.17m
BSXBoston Scientific Corp. 0.59%37.341.0%$281.37m
VARVarian Medical Systems, Inc. 0.07%171.989.1%$257.67m
BAXBaxter International, Inc. 1.20%79.651.8%$246.33m
ALGNAlign Technology, Inc. 1.94%317.936.4%$227.19m
EWEdwards Lifesciences Corp. 3.74%77.460.4%$226.03m

Company Profile

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.